TrialBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2019
PF-06439535 (a Bevacizumab Biosimilar) Compared with Reference Bevacizumab (Avastin
Niels Reinmuth et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this paperpooled ittrialcites it